Elizabeth M. Jaffee

Internal Medicine

600 N Wolfe St
Baltimore, MD 21287

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 291 publications

Synthetic long peptide and DNA personalized cancer vaccines induce robust neoantigen-specific T cell responses in pancreatic cancer.

Synthetic long peptide and DNA personalized cancer vaccines induce robust neoantigen-specific T cell responses in pancreatic cancer.

Journal: Science advances

Published: September 04, 2026

Modernizing Drug Development for Exceptional Therapies in High‑Unmet Need Diseases: A Call for Pragmatism and Patient Centricity.

Modernizing Drug Development for Exceptional Therapies in High‑Unmet Need Diseases: A Call for Pragmatism and Patient Centricity.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: August 06, 2026

Quantitative calibration of a spatial QSP model identifies fibroblast impact on HCC immunotherapy.

Quantitative calibration of a spatial QSP model identifies fibroblast impact on HCC immunotherapy.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: July 14, 2026

Publisher Correction: Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trial.

Publisher Correction: Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trial.

Journal: Nature communications

Published: April 15, 2026

CXCR2 blockade overcomes the NETosis-mediated resistance to MEK inhibition in pancreatic cancer models.

CXCR2 blockade overcomes the NETosis-mediated resistance to MEK inhibition in pancreatic cancer models.

Journal: The Journal of clinical investigation

Published: March 19, 2026

The Rising Burden of Early-Onset Cancer: Challenges and Opportunities.

The Rising Burden of Early-Onset Cancer: Challenges and Opportunities.

Journal: Cancer discovery

Published: February 15, 2026

Time-of-day of first checkpoint inhibitor dose influences clinical outcomes and immune responses in hepatocellular carcinoma.

Time-of-day of first checkpoint inhibitor dose influences clinical outcomes and immune responses in hepatocellular carcinoma.

Journal: Journal for immunotherapy of cancer

Published: February 02, 2026

First-in-human testing of a mutant KRAS vaccine for pancreatic cancer interception in high-risk cohorts.

First-in-human testing of a mutant KRAS vaccine for pancreatic cancer interception in high-risk cohorts.

Journal: Cancer discovery

Published: December 31, 2025

The Seven Ps of Cancer Interception.

The Seven Ps of Cancer Interception.

Journal: Cancer discovery

Published: December 31, 2025

A Roadmap to Transform Lung Cancer Outcomes: Priorities in Biology, Therapeutic Innovation, Early Detection, Prevention, and Interception.

A Roadmap to Transform Lung Cancer Outcomes: Priorities in Biology, Therapeutic Innovation, Early Detection, Prevention, and Interception.

Journal: Cancer discovery

Published: December 31, 2025

A Roadmap to Transform Lung Cancer Outcomes: Priorities in Biology, Therapeutic Innovation, Early Detection, Prevention and Interception.

A Roadmap to Transform Lung Cancer Outcomes: Priorities in Biology, Therapeutic Innovation, Early Detection, Prevention and Interception.

Journal: Cancer discovery

Published: December 31, 2025

Antigen-presenting cancer-associated fibroblasts in murine pancreatic tumors differentially regulate T-cell phenotype and function.

Antigen-presenting cancer-associated fibroblasts in murine pancreatic tumors differentially regulate T-cell phenotype and function.

Journal: Journal of immunology (Baltimore, Md. : 1950)

Published: December 29, 2025

Showing 1-12 of 291

Last Updated: 09/26/2026